1h Free Analyst Time
The gene therapy market is forecasted to grow by $4613.9 mn during 2022-2027, accelerating at a CAGR of 19.91% during the forecast period. The report on the gene therapy market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in special drug designations, benefits associated with gene therapy, and increasing prevalence of chronic diseases.
The gene therapy market is segmented as below:
- By Therapy Area
- Oncology
- CNS
- Ophthalmology
- Rare diseases
- Others
By Delivery Mode
- In vivo
- Ex vivo
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the gene therapy market covers the following areas:
- Gene therapy market sizing
- Gene therapy market forecast
- Gene therapy market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibit 06: Executive Summary - Chart on Market Segmentation by Delivery Mode
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global gene therapy market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global gene therapy market 2017 - 2021 ($ million)
4.2 Therapy area Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
4.3 Delivery mode Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Delivery mode Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Therapy Area
6.1 Market segments
Exhibit 30: Chart on Therapy Area - Market share 2022-2027 (%)
Exhibit 31: Data Table on Therapy Area - Market share 2022-2027 (%)
6.2 Comparison by Therapy Area
Exhibit 32: Chart on Comparison by Therapy Area
Exhibit 33: Data Table on Comparison by Therapy Area
6.3 Oncology - Market size and forecast 2022-2027
Exhibit 34: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
6.4 CNS - Market size and forecast 2022-2027
Exhibit 38: Chart on CNS - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on CNS - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on CNS - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on CNS - Year-over-year growth 2022-2027 (%)
6.5 Ophthalmology - Market size and forecast 2022-2027
Exhibit 42: Chart on Ophthalmology - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Ophthalmology - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Ophthalmology - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Ophthalmology - Year-over-year growth 2022-2027 (%)
6.6 Rare diseases - Market size and forecast 2022-2027
Exhibit 46: Chart on Rare diseases - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Rare diseases - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Rare diseases - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Rare diseases - Year-over-year growth 2022-2027 (%)
6.7 Others - Market size and forecast 2022-2027
Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Therapy Area
Exhibit 54: Market opportunity by Therapy Area ($ million)
7 Market Segmentation by Delivery Mode
7.1 Market segments
Exhibit 55: Chart on Delivery Mode - Market share 2022-2027 (%)
Exhibit 56: Data Table on Delivery Mode - Market share 2022-2027 (%)
7.2 Comparison by Delivery Mode
Exhibit 57: Chart on Comparison by Delivery Mode
Exhibit 58: Data Table on Comparison by Delivery Mode
7.3 In vivo - Market size and forecast 2022-2027
Exhibit 59: Chart on In vivo - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on In vivo - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on In vivo - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on In vivo - Year-over-year growth 2022-2027 (%)
7.4 Ex vivo - Market size and forecast 2022-2027
Exhibit 63: Chart on Ex vivo - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Ex vivo - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Ex vivo - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Ex vivo - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Delivery Mode
Exhibit 67: Market opportunity by Delivery Mode ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 69: Chart on Market share by geography 2022-2027 (%)
Exhibit 70: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 109: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 Abeona Therapeutics Inc.
Exhibit 116: Abeona Therapeutics Inc. - Overview
Exhibit 117: Abeona Therapeutics Inc. - Product/Service
Exhibit 118: Abeona Therapeutics Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 119: Amgen Inc. - Overview
Exhibit 120: Amgen Inc. - Product/Service
Exhibit 121: Amgen Inc. - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 122: Astellas Pharma Inc. - Overview
Exhibit 123: Astellas Pharma Inc. - Product/Service
Exhibit 124: Astellas Pharma Inc. - Key offerings
12.6 Biogen Inc.
Exhibit 125: Biogen Inc. - Overview
Exhibit 126: Biogen Inc. - Product/Service
Exhibit 127: Biogen Inc. - Key offerings
12.7 bluebird bio Inc.
Exhibit 128: bluebird bio Inc. - Overview
Exhibit 129: bluebird bio Inc. - Product/Service
Exhibit 130: bluebird bio Inc. - Key offerings
12.8 ElevateBio
Exhibit 131: ElevateBio - Overview
Exhibit 132: ElevateBio - Product/Service
Exhibit 133: ElevateBio - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Generation Bio Co.
Exhibit 139: Generation Bio Co. - Overview
Exhibit 140: Generation Bio Co. - Product/Service
Exhibit 141: Generation Bio Co. - Key offerings
12.11 Gilead Sciences Inc.
Exhibit 142: Gilead Sciences Inc. - Overview
Exhibit 143: Gilead Sciences Inc. - Product/Service
Exhibit 144: Gilead Sciences Inc. - Key news
Exhibit 145: Gilead Sciences Inc. - Key offerings
12.12 Novartis AG
Exhibit 146: Novartis AG - Overview
Exhibit 147: Novartis AG - Business segments
Exhibit 148: Novartis AG - Key offerings
Exhibit 149: Novartis AG - Segment focus
12.13 Orchard Therapeutics Plc
Exhibit 150: Orchard Therapeutics Plc - Overview
Exhibit 151: Orchard Therapeutics Plc - Product/Service
Exhibit 152: Orchard Therapeutics Plc - Key offerings
12.14 Poseida Therapeutics Inc.
Exhibit 153: Poseida Therapeutics Inc. - Overview
Exhibit 154: Poseida Therapeutics Inc. - Product/Service
Exhibit 155: Poseida Therapeutics Inc. - Key offerings
12.15 Sibiono GeneTech Co. Ltd.
Exhibit 156: Sibiono GeneTech Co. Ltd. - Overview
Exhibit 157: Sibiono GeneTech Co. Ltd. - Product/Service
Exhibit 158: Sibiono GeneTech Co. Ltd. - Key offerings
12.16 uniQure NV
Exhibit 159: uniQure NV - Overview
Exhibit 160: uniQure NV - Product/Service
Exhibit 161: uniQure NV - Key offerings
12.17 Voyager Therapeutics Inc.
Exhibit 162: Voyager Therapeutics Inc. - Overview
Exhibit 163: Voyager Therapeutics Inc. - Product/Service
Exhibit 164: Voyager Therapeutics Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits 6: Executive Summary - Chart on Market Segmentation by Delivery Mode
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global gene therapy market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Therapy area Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Delivery mode Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Therapy Area - Market share 2022-2027 (%)
Exhibits 31: Data Table on Therapy Area - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Therapy Area
Exhibits 33: Data Table on Comparison by Therapy Area
Exhibits 34: Chart on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on CNS - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on CNS - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on CNS - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on CNS - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Ophthalmology - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Ophthalmology - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Ophthalmology - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Ophthalmology - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Rare diseases - Market size and forecast 2022-2027 ($ million)
Exhibits 47: Data Table on Rare diseases - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Chart on Rare diseases - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Rare diseases - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Therapy Area ($ million)
Exhibits 55: Chart on Delivery Mode - Market share 2022-2027 (%)
Exhibits 56: Data Table on Delivery Mode - Market share 2022-2027 (%)
Exhibits 57: Chart on Comparison by Delivery Mode
Exhibits 58: Data Table on Comparison by Delivery Mode
Exhibits 59: Chart on In vivo - Market size and forecast 2022-2027 ($ million)
Exhibits 60: Data Table on In vivo - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Chart on In vivo - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on In vivo - Year-over-year growth 2022-2027 (%)
Exhibits 63: Chart on Ex vivo - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on Ex vivo - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on Ex vivo - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on Ex vivo - Year-over-year growth 2022-2027 (%)
Exhibits 67: Market opportunity by Delivery Mode ($ million)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share by geography 2022-2027 (%)
Exhibits 70: Data Table on Market share by geography 2022-2027 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 101: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 102: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 103: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 104: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 105: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 106: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 109: Market opportunity by geography ($ million)
Exhibits 110: Impact of drivers and challenges in 2022 and 2027
Exhibits 111: Overview on Criticality of inputs and Factors of differentiation
Exhibits 112: Overview on factors of disruption
Exhibits 113: Impact of key risks on business
Exhibits 114: Vendors covered
Exhibits 115: Matrix on vendor position and classification
Exhibits 116: Abeona Therapeutics Inc. - Overview
Exhibits 117: Abeona Therapeutics Inc. - Product/Service
Exhibits 118: Abeona Therapeutics Inc. - Key offerings
Exhibits 119: Amgen Inc. - Overview
Exhibits 120: Amgen Inc. - Product/Service
Exhibits 121: Amgen Inc. - Key offerings
Exhibits 122: Astellas Pharma Inc. - Overview
Exhibits 123: Astellas Pharma Inc. - Product/Service
Exhibits 124: Astellas Pharma Inc. - Key offerings
Exhibits 125: Biogen Inc. - Overview
Exhibits 126: Biogen Inc. - Product/Service
Exhibits 127: Biogen Inc. - Key offerings
Exhibits 128: bluebird bio Inc. - Overview
Exhibits 129: bluebird bio Inc. - Product/Service
Exhibits 130: bluebird bio Inc. - Key offerings
Exhibits 131: ElevateBio - Overview
Exhibits 132: ElevateBio - Product/Service
Exhibits 133: ElevateBio - Key offerings
Exhibits 134: F. Hoffmann La Roche Ltd. - Overview
Exhibits 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 136: F. Hoffmann La Roche Ltd. - Key news
Exhibits 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 138: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 139: Generation Bio Co. - Overview
Exhibits 140: Generation Bio Co. - Product/Service
Exhibits 141: Generation Bio Co. - Key offerings
Exhibits 142: Gilead Sciences Inc. - Overview
Exhibits 143: Gilead Sciences Inc. - Product/Service
Exhibits 144: Gilead Sciences Inc. - Key news
Exhibits 145: Gilead Sciences Inc. - Key offerings
Exhibits 146: Novartis AG - Overview
Exhibits 147: Novartis AG - Business segments
Exhibits 148: Novartis AG - Key offerings
Exhibits 149: Novartis AG - Segment focus
Exhibits 150: Orchard Therapeutics Plc - Overview
Exhibits 151: Orchard Therapeutics Plc - Product/Service
Exhibits 152: Orchard Therapeutics Plc - Key offerings
Exhibits 153: Poseida Therapeutics Inc. - Overview
Exhibits 154: Poseida Therapeutics Inc. - Product/Service
Exhibits 155: Poseida Therapeutics Inc. - Key offerings
Exhibits 156: Sibiono GeneTech Co. Ltd. - Overview
Exhibits 157: Sibiono GeneTech Co. Ltd. - Product/Service
Exhibits 158: Sibiono GeneTech Co. Ltd. - Key offerings
Exhibits 159: uniQure NV - Overview
Exhibits 160: uniQure NV - Product/Service
Exhibits 161: uniQure NV - Key offerings
Exhibits 162: Voyager Therapeutics Inc. - Overview
Exhibits 163: Voyager Therapeutics Inc. - Product/Service
Exhibits 164: Voyager Therapeutics Inc. - Key offerings
Exhibits 165: Inclusions checklist
Exhibits 166: Exclusions checklist
Exhibits 167: Currency conversion rates for US$
Exhibits 168: Research methodology
Exhibits 169: Validation techniques employed for market sizing
Exhibits 170: Information sources
Exhibits 171: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global gene therapy market: Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Amgen Inc., Astellas Pharma Inc., Biogen Inc., bluebird bio Inc., Editas Medicine Inc., ElevateBio, F. Hoffmann La Roche Ltd., Generation Bio Co., Gilead Sciences Inc., Novartis AG, Orchard Therapeutics Plc, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Sibiono GeneTech Co. Ltd., Syncona Ltd., uniQure NV, and Voyager Therapeutics Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing research in gene therapy for CVDs and orphan diseases.`
According to the report, one of the major drivers for this market is the increase in special drug designations.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abeona Therapeutics Inc.
- Adaptimmune Therapeutics plc
- Adverum Biotechnologies Inc.
- Amgen Inc.
- Astellas Pharma Inc.
- Biogen Inc.
- bluebird bio Inc.
- Editas Medicine Inc.
- ElevateBio
- F. Hoffmann La Roche Ltd.
- Generation Bio Co.
- Gilead Sciences Inc.
- Novartis AG
- Orchard Therapeutics Plc
- Poseida Therapeutics Inc.
- Sangamo Therapeutics Inc.
- Sibiono GeneTech Co. Ltd.
- Syncona Ltd.
- uniQure NV
- Voyager Therapeutics Inc.
